Company & Sponsor Intelligence
University of Minnesota
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials24
Recruiting4
Completed14
Countries1
Therapeutic footprint
adhdalzheimersautismdepressioneating_disordersepilepsypain_neuropathyparkinsonsschizophreniastroke
Indexed studies
NCT04055532Biomarkers in Neurodegenerative Diseases
alzheimers · United StatesWITHDRAWN
alzheimers · United StatesWITHDRAWN
NCT02090829Intranasal Oxytocin and Learning in Autism
autism · United StatesPHASE2
autism · United StatesPHASE2
NCT00053625Deep Brain Stimulation for Parkinson's Disease Trial
parkinsons · United StatesPHASE3
parkinsons · United StatesPHASE3
NCT06961851Feasibility Pilot of Accelerated Stimulation With TMS for Treatment of Major Depressive Disorder (FAST-MDD)
depression · United StatesEARLY_PHASE1
depression · United StatesEARLY_PHASE1
NCT04938245Improving Spinal Cord Stimulation With ECAPS
pain_neuropathy · United StatesRECRUITING
pain_neuropathy · United StatesRECRUITING
NCT01427517Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease
parkinsons · United StatesPHASE1
parkinsons · United StatesPHASE1
NCT05656586Udall Project 2 Aim 2A&C
parkinsons · United StatesRECRUITING
parkinsons · United StatesRECRUITING
NCT02493426Single Dose Intranasal Oxytocin and Cognitive Effects in Autism
autism · United StatesPHASE2
autism · United StatesPHASE2
NCT02460809Home-based Non-invasive Brain Stimulation and Hand Tracking Rehabilitation for People With Chronic Stroke
stroke · United StatesNA
stroke · United StatesNA
NCT02722213Mindfulness & Stress Management Study for Cardiac Patients
pain_neuropathy · United StatesNA
pain_neuropathy · United StatesNA
NCT03901456Care to Plan: a Tailored Resource for Family Members of Persons With Dementia
alzheimers · United StatesNA
alzheimers · United StatesNA
NCT02002819Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability
alzheimers · United StatesPHASE2
alzheimers · United StatesPHASE2
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →